{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T14:58:58Z","timestamp":1793285938598,"version":"4.5.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,11,13]],"date-time":"2017-11-13T00:00:00Z","timestamp":1510531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,11,13]],"date-time":"2017-11-13T00:00:00Z","timestamp":1510531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The \u03b54 allele of apolipoprotein E (\n                    <jats:italic>APOE<\/jats:italic>\n                    ) is the dominant genetic risk factor for late-onset Alzheimer\u2019s disease (AD). However, the reason\n                    <jats:italic>APOE4<\/jats:italic>\n                    is associated with increased AD risk remains a source of debate. Neuronal hyperactivity is an early phenotype in both AD mouse models and in human AD, which may play a direct role in the pathogenesis of the disease. Here, we have identified an\n                    <jats:italic>APOE4<\/jats:italic>\n                    -associated hyperactivity phenotype in the brains of aged\n                    <jats:italic>APOE<\/jats:italic>\n                    mice using four complimentary techniques\u2014fMRI, in vitro electrophysiology, in vivo electrophysiology, and metabolomics\u2014with the most prominent hyperactivity occurring in the entorhinal cortex. Further analysis revealed that this neuronal hyperactivity is driven by decreased background inhibition caused by reduced responsiveness of excitatory neurons to GABAergic inhibitory inputs. Given the observations of neuronal hyperactivity in prodromal AD, we propose that this\n                    <jats:italic>APOE4<\/jats:italic>\n                    -driven hyperactivity may be a causative factor driving increased risk of AD among\n                    <jats:italic>APOE4<\/jats:italic>\n                    carriers.\n                  <\/jats:p>","DOI":"10.1038\/s41467-017-01444-0","type":"journal-article","created":{"date-parts":[[2017,11,7]],"date-time":"2017-11-07T12:42:48Z","timestamp":1510058568000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":191,"title":["Neuronal hyperactivity due to loss of inhibitory tone in APOE4 mice lacking Alzheimer\u2019s disease-like pathology"],"prefix":"10.1038","volume":"8","author":[{"given":"Tal","family":"Nuriel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio L.","family":"Angulo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usman","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archana","family":"Ashok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen Y.","family":"Figueroa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheina","family":"Emrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Herman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5129-6348","authenticated-orcid":false,"given":"Geoffrey","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Savage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luna","family":"Buitrago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efrain","family":"Cepeda-Prado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Fung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliana","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven S.","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Abid","family":"Hussaini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herman","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott A.","family":"Small","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6177-868X","authenticated-orcid":false,"given":"Karen E.","family":"Duff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,13]]},"reference":[{"key":"1444_CR1","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","volume":"278","author":"LA Farrer","year":"1997","unstructured":"Farrer, L. A. et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA \n                           278, 1349\u20131356 (1997).","journal-title":"JAMA"},{"key":"1444_CR2","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1146\/annurev.genom.1.1.507","volume":"1","author":"RW Mahley","year":"2000","unstructured":"Mahley, R. W. & Rall, S. C. Jr. Apolipoprotein E: far more than a lipid transport protein. Annu. Rev. Genomics Hum. Genet. \n                           1, 507\u2013537 (2000).","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"1444_CR3","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1007\/s00018-004-4009-z","volume":"61","author":"X Han","year":"2004","unstructured":"Han, X. The role of apolipoprotein E in lipid metabolism in the central nervous system. Cell Mol. Life Sci. \n                           61, 1896\u20131906 (2004).","journal-title":"Cell Mol. Life Sci."},{"key":"1444_CR4","volume":"2","author":"DM Holtzman","year":"2012","unstructured":"Holtzman, D. M., Herz, J. & Bu, G. Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease. Cold Spring Harb. Perspect. Med. \n                           2, a006312 (2012).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"1444_CR5","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/ng1197-263","volume":"17","author":"KR Bales","year":"1997","unstructured":"Bales, K. R. et al. Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition. Nat. Genet. \n                           17, 263\u2013264 (1997).","journal-title":"Nat. Genet."},{"issue":"Pt 2","key":"1444_CR6","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1042\/bj3060599","volume":"306","author":"EM Castano","year":"1995","unstructured":"Castano, E. M. et al. Fibrillogenesis in Alzheimer\u2019s disease of amyloid beta peptides and apolipoprotein E. Biochem. J. \n                           306(Pt 2) 599\u2013604 (1995).","journal-title":"Biochem. J."},{"key":"1444_CR7","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/0896-6273(93)90070-8","volume":"11","author":"GW Rebeck","year":"1993","unstructured":"Rebeck, G. W., Reiter, J. S., Strickland, D. K. & Hyman, B. T. Apolipoprotein E in sporadic Alzheimer\u2019s disease: allelic variation and receptor interactions. Neuron \n                           11, 575\u2013580 (1993).","journal-title":"Neuron"},{"key":"1444_CR8","doi-asserted-by":"publisher","first-page":"9649","DOI":"10.1073\/pnas.90.20.9649","volume":"90","author":"DE Schmechel","year":"1993","unstructured":"Schmechel, D. E. et al. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc. Natl Acad. Sci. USA \n                           90, 9649\u20139653 (1993).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1444_CR9","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/372092a0","volume":"372","author":"J Ma","year":"1994","unstructured":"Ma, J. et al. Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments. Nature \n                           372, 92\u201394 (1994).","journal-title":"Nature"},{"key":"1444_CR10","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3002156","volume":"3","author":"JM Castellano","year":"2011","unstructured":"Castellano, J. M. et al. Human apoE isoforms differentially regulate brain amyloid-beta peptide clearance. Sci. Transl. Med. \n                           3, 89ra57 (2011).","journal-title":"Sci. Transl. Med."},{"key":"1444_CR11","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1073\/pnas.050004797","volume":"97","author":"DM Holtzman","year":"2000","unstructured":"Holtzman, D. M. et al. Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer\u2019s disease. Proc. Natl Acad. Sci. USA \n                           97, 2892\u20132897 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1444_CR12","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.molmed.2010.04.004","volume":"16","author":"Y Huang","year":"2010","unstructured":"Huang, Y. Abeta-independent roles of apolipoprotein E4 in the pathogenesis of Alzheimer\u2019s disease. Trends Mol. Med. \n                           16, 287\u2013294 (2010).","journal-title":"Trends Mol. Med."},{"key":"1444_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/alzrt204","volume":"5","author":"AB Wolf","year":"2013","unstructured":"Wolf, A. B. et al. Apolipoprotein E as a beta-amyloid-independent factor in alzheimer\u2019s disease. Alzheimers Res. Ther. \n                           5, 38 (2013).","journal-title":"Alzheimers Res. Ther."},{"key":"1444_CR14","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1038\/nn.4163","volume":"18","author":"MA Busche","year":"2015","unstructured":"Busche, M. A. et al. Decreased amyloid-beta and increased neuronal hyperactivity by immunotherapy in Alzheimer\u2019s models. Nat. Neurosci. \n                           18, 1725\u20137 (2015).","journal-title":"Nat. Neurosci."},{"key":"1444_CR15","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1126\/science.1162844","volume":"321","author":"MA Busche","year":"2008","unstructured":"Busche, M. A. et al. Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer\u2019s disease. Science \n                           321, 1686\u20131689 (2008).","journal-title":"Science"},{"key":"1444_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0091203","volume":"9","author":"KE Davis","year":"2014","unstructured":"Davis, K. E., Fox, S. & Gigg, J. Increased hippocampal excitability in the 3xTgAD mouse model for Alzheimer\u2019s disease in vivo. PLoS ONE \n                           9, e91203 (2014).","journal-title":"PLoS ONE"},{"key":"1444_CR17","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.neuron.2007.07.025","volume":"55","author":"JJ Palop","year":"2007","unstructured":"Palop, J. J. et al. Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer\u2019s disease. Neuron \n                           55, 697\u2013711 (2007).","journal-title":"Neuron"},{"key":"1444_CR18","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1016\/j.neurobiolaging.2006.08.008","volume":"28","author":"A Hamalainen","year":"2007","unstructured":"Hamalainen, A. et al. Increased fMRI responses during encoding in mild cognitive impairment. Neurobiol. Aging \n                           28, 1889\u20131903 (2007).","journal-title":"Neurobiol. Aging"},{"key":"1444_CR19","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1136\/jnnp.2006.104877","volume":"78","author":"TT Kircher","year":"2007","unstructured":"Kircher, T. T. et al. Hippocampal activation in patients with mild cognitive impairment is necessary for successful memory encoding. J. Neurol. Neurosurg. Psychiatry \n                           78, 812\u2013818 (2007).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1444_CR20","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.neuron.2012.03.023","volume":"74","author":"A Bakker","year":"2012","unstructured":"Bakker, A. et al. Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment. Neuron \n                           74, 467\u2013474 (2012).","journal-title":"Neuron"},{"key":"1444_CR21","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1212\/01.wnl.0000171450.97464.49","volume":"65","author":"BC Dickerson","year":"2005","unstructured":"Dickerson, B. C. et al. Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD. Neurology \n                           65, 404\u2013411 (2005).","journal-title":"Neurology"},{"key":"1444_CR22","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1136\/jnnp.2007.124149","volume":"79","author":"SL Miller","year":"2008","unstructured":"Miller, S. L. et al. Hippocampal activation in adults with mild cognitive impairment predicts subsequent cognitive decline. J. Neurol. Neurosurg. Psychiatry \n                           79, 630\u2013635 (2008).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1444_CR23","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1002\/ana.22105","volume":"68","author":"YT Quiroz","year":"2010","unstructured":"Quiroz, Y. T. et al. Hippocampal hyperactivation in presymptomatic familial Alzheimer\u2019s disease. Ann. Neurol. \n                           68, 865\u2013875 (2010).","journal-title":"Ann. Neurol."},{"key":"1444_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JAD-2012-120907","volume":"32","author":"D Sepulveda-Falla","year":"2012","unstructured":"Sepulveda-Falla, D., Glatzel, M. & Lopera, F. Phenotypic profile of early-onset familial Alzheimer\u2019s disease caused by presenilin-1 E280A mutation. J. Alzheimers Dis. \n                           32, 1\u201312 (2012).","journal-title":"J. Alzheimers Dis."},{"key":"1444_CR25","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.neuron.2013.05.035","volume":"79","author":"U Das","year":"2013","unstructured":"Das, U. et al. Activity-induced convergence of APP and BACE-1 in acidic microdomains via an endocytosis-dependent pathway. Neuron \n                           79, 447\u2013460 (2013).","journal-title":"Neuron"},{"key":"1444_CR26","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.neuron.2005.10.028","volume":"48","author":"JR Cirrito","year":"2005","unstructured":"Cirrito, J. R. et al. Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. Neuron \n                           48, 913\u2013922 (2005).","journal-title":"Neuron"},{"key":"1444_CR27","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.celrep.2015.04.017","volume":"11","author":"K Yamamoto","year":"2015","unstructured":"Yamamoto, K. et al. Chronic optogenetic activation augments abeta pathology in a mouse model of Alzheimer disease. Cell Rep. \n                           11, 859\u2013865 (2015).","journal-title":"Cell Rep."},{"key":"1444_CR28","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/embor.2013.15","volume":"14","author":"AM Pooler","year":"2013","unstructured":"Pooler, A. M., Phillips, E. C., Lau, D. H., Noble, W. & Hanger, D. P. Physiological release of endogenous tau is stimulated by neuronal activity. EMBO Rep. \n                           14, 389\u2013394 (2013).","journal-title":"EMBO Rep."},{"key":"1444_CR29","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1084\/jem.20131685","volume":"211","author":"K Yamada","year":"2014","unstructured":"Yamada, K. et al. Neuronal activity regulates extracellular tau in vivo. J. Exp. Med. \n                           211, 387\u2013393 (2014).","journal-title":"J. Exp. Med."},{"key":"1444_CR30","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1038\/nn.4328","volume":"19","author":"JW Wu","year":"2016","unstructured":"Wu, J. W. et al. Neuronal activity enhances tau propagation and tau pathology in vivo. Nat. Neurosci. \n                           19, 1085\u201392 (2016).","journal-title":"Nat. Neurosci."},{"key":"1444_CR31","doi-asserted-by":"publisher","first-page":"7209","DOI":"10.1073\/pnas.0811879106","volume":"106","author":"N Filippini","year":"2009","unstructured":"Filippini, N. et al. Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele. Proc. Natl Acad. Sci. USA \n                           106, 7209\u20137214 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1444_CR32","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1056\/NEJM200008173430701","volume":"343","author":"SY Bookheimer","year":"2000","unstructured":"Bookheimer, S. Y. et al. Patterns of brain activation in people at risk for Alzheimer\u2019s disease. N. Engl. J. Med. \n                           343, 450\u2013456 (2000).","journal-title":"N. Engl. J. Med."},{"key":"1444_CR33","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.neurobiolaging.2010.03.009","volume":"33","author":"AJ Trachtenberg","year":"2012","unstructured":"Trachtenberg, A. J., Filippini, N. & Mackay, C. E. The effects of APOE-epsilon4 on the BOLD response. Neurobiol. Aging \n                           33, 323\u2013334 (2012).","journal-title":"Neurobiol. Aging"},{"key":"1444_CR34","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1016\/j.neurobiolaging.2008.01.012","volume":"30","author":"AS Fleisher","year":"2009","unstructured":"Fleisher, A. S. et al. Cerebral perfusion and oxygenation differences in Alzheimer\u2019s disease risk. Neurobiol. Aging \n                           30, 1737\u20131748 (2009).","journal-title":"Neurobiol. Aging"},{"key":"1444_CR35","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1038\/jcbfm.2012.58","volume":"32","author":"CE Wierenga","year":"2012","unstructured":"Wierenga, C. E. et al. Effect of mild cognitive impairment and APOE genotype on resting cerebral blood flow and its association with cognition. J. Cereb. Blood Flow Metab. \n                           32, 1589\u20131599 (2012).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"1444_CR36","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","volume":"12","author":"CR Jack Jr","year":"2013","unstructured":"Jack, C. R. Jr et al. Tracking pathophysiological processes in Alzheimer\u2019s disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. \n                           12, 207\u2013216 (2013).","journal-title":"Lancet Neurol."},{"key":"1444_CR37","doi-asserted-by":"publisher","first-page":"17972","DOI":"10.1074\/jbc.272.29.17972","volume":"272","author":"PM Sullivan","year":"1997","unstructured":"Sullivan, P. M. et al. Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis. J. Biol. Chem. \n                           272, 17972\u201317980 (1997).","journal-title":"J. Biol. Chem."},{"key":"1444_CR38","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.neuroscience.2003.10.011","volume":"124","author":"PM Sullivan","year":"2004","unstructured":"Sullivan, P. M., Mace, B. E., Maeda, N. & Schmechel, D. E. Marked regional differences of brain human apolipoprotein E expression in targeted replacement mice. Neuroscience \n                           124, 725\u2013733 (2004).","journal-title":"Neuroscience"},{"key":"1444_CR39","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/nbm.1022","volume":"19","author":"H Moreno","year":"2006","unstructured":"Moreno, H., Hua, F., Brown, T. & Small, S.A. Longitudinal mapping of mouse cerebral blood volume with MRI. NMR in Biomedicine \n                           19, 535\u2013543 (2006).","journal-title":"NMR in Biomedicine"},{"key":"1444_CR40","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1001\/archneur.64.10.1467","volume":"64","author":"H Moreno","year":"2007","unstructured":"Moreno, H. et al. Imaging the abeta-related neurotoxicity of Alzheimer disease. Arch. Neurol. \n                           64, 1467\u20131477 (2007).","journal-title":"Arch. Neurol."},{"key":"1444_CR41","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1146\/annurev.ne.06.030183.001341","volume":"6","author":"ME Raichle","year":"1983","unstructured":"Raichle, M. E. Positron emission tomography. Annu. Rev. Neurosci. \n                           6, 249\u2013267 (1983).","journal-title":"Annu. Rev. Neurosci."},{"key":"1444_CR42","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/brain\/113.1.27","volume":"113","author":"KL Leenders","year":"1990","unstructured":"Leenders, K. L. et al. Cerebral blood flow, blood volume and oxygen utilization. Normal values and effect of age. Brain \n                           113, 27\u201347 (1990). (Pt 1).","journal-title":"Brain"},{"key":"1444_CR43","first-page":"1763","volume":"16","author":"RG Gonzalez","year":"1995","unstructured":"Gonzalez, R. G. et al. Functional MR in the evaluation of dementia: correlation of abnormal dynamic cerebral blood volume measurements with changes in cerebral metabolism on positron emission tomography with fludeoxyglucose F 18. Am. J. Neuroradiol. \n                           16, 1763\u20131770 (1995).","journal-title":"Am. J. Neuroradiol."},{"key":"1444_CR44","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak, H. & Braak, E. Neuropathological stageing of Alzheimer-related changes. Acta. Neuropathol. \n                           82, 239\u2013259 (1991).","journal-title":"Acta. Neuropathol."},{"key":"1444_CR45","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.neuroimage.2011.06.025","volume":"58","author":"K Richards","year":"2011","unstructured":"Richards, K. et al. Segmentation of the mouse hippocampal formation in magnetic resonance images. Neuroimage \n                           58, 732\u2013740 (2011).","journal-title":"Neuroimage"},{"key":"1444_CR46","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.neuron.2011.09.007","volume":"72","author":"SA Hussaini","year":"2011","unstructured":"Hussaini, S. A., Kempadoo, K. A., Thuault, S. J., Siegelbaum, S. A. & Kandel, E. R. Increased size and stability of CA1 and CA3 place fields in HCN1 knockout mice. Neuron \n                           72, 643\u2013653 (2011).","journal-title":"Neuron"},{"key":"1444_CR47","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nn.3614","volume":"17","author":"K Kohara","year":"2014","unstructured":"Kohara, K. et al. Cell type-specific genetic and optogenetic tools reveal hippocampal CA2 circuits. Nat. Neurosci. \n                           17, 269\u2013279 (2014).","journal-title":"Nat. Neurosci."},{"key":"1444_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/neuro.06.013.2009","volume":"3","author":"MC Quirk","year":"2009","unstructured":"Quirk, M. C., Sosulski, D. L., Feierstein, C. E., Uchida, N. & Mainen, Z. F. A defined network of fast-spiking interneurons in orbitofrontal cortex: responses to behavioral contingencies and ketamine administration. Front. Syst. Neurosci. \n                           3, 13 (2009).","journal-title":"Front. Syst. Neurosci."},{"key":"1444_CR49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0037149","volume":"7","author":"Q Chen","year":"2012","unstructured":"Chen, Q. et al. Untargeted plasma metabolite profiling reveals the broad systemic consequences of xanthine oxidoreductase inactivation in mice. PLoS ONE \n                           7, e37149 (2012).","journal-title":"PLoS ONE"},{"key":"1444_CR50","doi-asserted-by":"publisher","first-page":"618","DOI":"10.2174\/138920210793360943","volume":"11","author":"X Wang","year":"2010","unstructured":"Wang, X., Michaelis, M. L. & Michaelis, E. K. Functional genomics of brain aging and Alzheimer\u2019s disease: focus on selective neuronal vulnerability. Curr. Genomics \n                           11, 618\u2013633 (2010).","journal-title":"Curr. Genomics"},{"key":"1444_CR51","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/ana.410420114","volume":"42","author":"S Minoshima","year":"1997","unstructured":"Minoshima, S. et al. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer\u2019s disease. Ann. Neurol. \n                           42, 85\u201394 (1997).","journal-title":"Ann. Neurol."},{"key":"1444_CR52","doi-asserted-by":"publisher","first-page":"6456","DOI":"10.1523\/JNEUROSCI.0388-12.2012","volume":"32","author":"E Cepeda-Prado","year":"2012","unstructured":"Cepeda-Prado, E. et al. R6\/2 Huntington\u2019s disease mice develop early and progressive abnormal brain metabolism and seizures. J. Neurosci. \n                           32, 6456\u20136467 (2012).","journal-title":"J. Neurosci."},{"key":"1444_CR53","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/0304-3940(86)90595-1","volume":"69","author":"H Walther","year":"1986","unstructured":"Walther, H., Lambert, J. D., Jones, R. S., Heinemann, U. & Hamon, B. Epileptiform activity in combined slices of the hippocampus, subiculum and entorhinal cortex during perfusion with low magnesium medium. Neurosci. Lett. \n                           69, 156\u2013161 (1986).","journal-title":"Neurosci. Lett."},{"key":"1444_CR54","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1002\/hipo.20016","volume":"14","author":"A Kunitake","year":"2004","unstructured":"Kunitake, A., Kunitake, T. & Stewart, M. Differential modulation by carbachol of four separate excitatory afferent systems to the rat subiculum in vitro. Hippocampus \n                           14, 986\u2013999 (2004).","journal-title":"Hippocampus"},{"key":"1444_CR55","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/j.neurobiolaging.2014.11.016","volume":"36","author":"C Criscuolo","year":"2015","unstructured":"Criscuolo, C. et al. BDNF prevents amyloid-dependent impairment of LTP in the entorhinal cortex by attenuating p38 MAPK phosphorylation. Neurobiol. Aging \n                           36, 1303\u20131309 (2015).","journal-title":"Neurobiol. Aging"},{"key":"1444_CR56","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1002\/hipo.20997","volume":"22","author":"CB Canto","year":"2012","unstructured":"Canto, C. B. & Witter, M. P. Cellular properties of principal neurons in the rat entorhinal cortex. I. The lateral entorhinal cortex. Hippocampus \n                           22, 1256\u20131276 (2012).","journal-title":"Hippocampus"},{"key":"1444_CR57","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1152\/jn.1993.70.1.128","volume":"70","author":"A Alonso","year":"1993","unstructured":"Alonso, A. & Klink, R. Differential electroresponsiveness of stellate and pyramidal-like cells of medial entorhinal cortex layer II. J. Neurophysiol. \n                           70, 128\u2013143 (1993).","journal-title":"J. Neurophysiol."},{"key":"1444_CR58","doi-asserted-by":"crossref","first-page":"6427","DOI":"10.1523\/JNEUROSCI.19-15-06427.1999","volume":"19","author":"O Prange","year":"1999","unstructured":"Prange, O. & Murphy, T. H. Correlation of miniature synaptic activity and evoked release probability in cultures of cortical neurons. J. Neurosci. \n                           19, 6427\u20136438 (1999).","journal-title":"J. Neurosci."},{"key":"1444_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1326-8-16","volume":"8","author":"O Liraz","year":"2013","unstructured":"Liraz, O., Boehm-Cagan, A. & Michaelson, D. M. ApoE4 induces Abeta42, tau, and neuronal pathology in the hippocampus of young targeted replacement apoE4 mice. Mol. Neurodegener. \n                           8, 16 (2013).","journal-title":"Mol. Neurodegener."},{"key":"1444_CR60","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.jstrokecerebrovasdis.2008.03.011","volume":"17","author":"PM Sullivan","year":"2008","unstructured":"Sullivan, P. M., Mace, B. E., Estrada, J. C., Schmechel, D. E. & Alberts, M. J. Human apolipoprotein E4 targeted replacement mice show increased prevalence of intracerebral hemorrhage associated with vascular amyloid deposition. J. Stroke Cerebrovasc. Dis. \n                           17, 303\u2013311 (2008).","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"1444_CR61","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1016\/j.neurobiolaging.2014.02.019","volume":"35","author":"RC Klein","year":"2014","unstructured":"Klein, R. C., Acheson, S. K., Mace, B. E., Sullivan, P. M. & Moore, S. D. Altered neurotransmission in the lateral amygdala in aged human apoE4 targeted replacement mice. Neurobiol. Aging \n                           35, 2046\u20132052 (2014).","journal-title":"Neurobiol. Aging"},{"key":"1444_CR62","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.brainres.2012.05.048","volume":"1467","author":"JM Hunter","year":"2012","unstructured":"Hunter, J. M. et al. Emergence of a seizure phenotype in aged apolipoprotein epsilon 4 targeted replacement mice. Brain Res. \n                           1467, 120\u2013132 (2012).","journal-title":"Brain Res."},{"key":"1444_CR63","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.neuron.2016.04.009","volume":"90","author":"AK Gillespie","year":"2016","unstructured":"Gillespie, A. K. et al. Apolipoprotein E4 causes age-dependent disruption of slow gamma Oscillations during Hippocampal sharp-wave ripples. Neuron \n                           90, 740\u2013751 (2016).","journal-title":"Neuron"},{"key":"1444_CR64","doi-asserted-by":"publisher","first-page":"8605","DOI":"10.1523\/JNEUROSCI.0294-11.2011","volume":"31","author":"D Sullivan","year":"2011","unstructured":"Sullivan, D. et al. Relationships between hippocampal sharp waves, ripples, and fast gamma oscillation: influence of dentate and entorhinal cortical activity. J. Neurosci. \n                           31, 8605\u20138616 (2011).","journal-title":"J. Neurosci."},{"key":"1444_CR65","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1212\/01.WNL.0000098935.36984.25","volume":"61","author":"RJ Haier","year":"2003","unstructured":"Haier, R. J. et al. Temporal cortex hypermetabolism in down syndrome prior to the onset of dementia. Neurology \n                           61, 1673\u20131679 (2003).","journal-title":"Neurology"},{"key":"1444_CR66","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1002\/1531-8249(199904)45:4<466::AID-ANA8>3.0.CO;2-Q","volume":"45","author":"SA Small","year":"1999","unstructured":"Small, S. A., Perera, G. M., DeLaPaz, R., Mayeux, R. & Stern, Y. Differential regional dysfunction of the hippocampal formation among elderly with memory decline and Alzheimer\u2019s disease. Ann. Neurol. \n                           45, 466\u2013472 (1999).","journal-title":"Ann. Neurol."},{"key":"1444_CR67","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/ana.10105","volume":"51","author":"SA Small","year":"2002","unstructured":"Small, S. A., Tsai, W. Y., DeLaPaz, R., Mayeux, R. & Stern, Y. Imaging hippocampal function across the human life span: is memory decline normal or not? Ann. Neurol. \n                           51, 290\u2013295 (2002).","journal-title":"Ann. Neurol."},{"key":"1444_CR68","doi-asserted-by":"publisher","first-page":"10966","DOI":"10.1073\/pnas.191044198","volume":"98","author":"MJ de Leon","year":"2001","unstructured":"de Leon, M. J. et al. Prediction of cognitive decline in normal elderly subjects with 2-[(18)F]fluoro-2-deoxy-D-glucose\/poitron-emission tomography (FDG\/PET). Proc. Natl Acad. Sci. USA \n                           98, 10966\u201310971 (2001).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1444_CR69","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1148\/radiol.10091402","volume":"256","author":"DS Karow","year":"2010","unstructured":"Karow, D. S. et al. Relative capability of MR imaging and FDG PET to depict changes associated with prodromal and early Alzheimer disease. Radiology \n                           256, 932\u2013942 (2010).","journal-title":"Radiology"},{"key":"1444_CR70","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/nn.3606","volume":"17","author":"UA Khan","year":"2014","unstructured":"Khan, U. A. et al. Molecular drivers and cortical spread of lateral entorhinal cortex dysfunction in preclinical Alzheimer\u2019s disease. Nat. Neurosci. \n                           17, 304\u2013311 (2014).","journal-title":"Nat. Neurosci."},{"key":"1444_CR71","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/416535a","volume":"416","author":"DM Walsh","year":"2002","unstructured":"Walsh, D. M. et al. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature \n                           416, 535\u2013539 (2002).","journal-title":"Nature"},{"key":"1444_CR72","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/nm1782","volume":"14","author":"GM Shankar","year":"2008","unstructured":"Shankar, G. M. et al. Amyloid-beta protein dimers isolated directly from Alzheimer\u2019s brains impair synaptic plasticity and memory. Nat. Med. \n                           14, 837\u2013842 (2008).","journal-title":"Nat. Med."},{"key":"1444_CR73","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/S0896-6273(03)00124-7","volume":"37","author":"F Kamenetz","year":"2003","unstructured":"Kamenetz, F. et al. APP processing and synaptic function. Neuron \n                           37, 925\u2013937 (2003).","journal-title":"Neuron"},{"key":"1444_CR74","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1523\/JNEUROSCI.16-14-04491.1996","volume":"16","author":"T Gomez-Isla","year":"1996","unstructured":"Gomez-Isla, T. et al. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer\u2019s disease. J. Neurosci. \n                           16, 4491\u20134500 (1996).","journal-title":"J. Neurosci."},{"key":"1444_CR75","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.neuron.2010.11.030","volume":"68","author":"BR Hoover","year":"2010","unstructured":"Hoover, B. R. et al. Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration. Neuron \n                           68, 1067\u20131081 (2010).","journal-title":"Neuron"},{"key":"1444_CR76","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1155\/2009\/246892","volume":"21","author":"AM Brickman","year":"2009","unstructured":"Brickman, A. M., Small, S. A. & Fleisher, A. Pinpointing synaptic loss caused by Alzheimer\u2019s disease with fMRI. Behav. Neurol. \n                           21, 93\u2013100 (2009).","journal-title":"Behav. Neurol."},{"key":"1444_CR77","first-page":"565","volume":"12","author":"MR Sabuncu","year":"2009","unstructured":"Sabuncu, M. R., Yeo, B. T., Van Leemput, K., Vercauteren, T. & Golland, P. Asymmetric image-template registration. Med. Image Comput. Comput. Assist. Interv. \n                           12, 565\u2013573 (2009).","journal-title":"Med. Image Comput. Comput. Assist. Interv."},{"key":"1444_CR78","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1194\/jlr.D700041-JLR200","volume":"49","author":"V Matyash","year":"2008","unstructured":"Matyash, V., Liebisch, G., Kurzchalia, T. V., Shevchenko, A. & Schwudke, D. Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics. J. Lipid Res. \n                           49, 1137\u20131146 (2008).","journal-title":"J. Lipid Res."},{"key":"1444_CR79","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/j.1365-313X.2011.04682.x","volume":"68","author":"P Giavalisco","year":"2011","unstructured":"Giavalisco, P. et al. Elemental formula annotation of polar and lipophilic metabolites using (13) C, (15) N and (34) S isotope labelling, in combination with high-resolution mass spectrometry. Plant J. \n                           68, 364\u2013376 (2011).","journal-title":"Plant J."},{"key":"1444_CR80","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/hipo.20047","volume":"15","author":"GL Woodhall","year":"2005","unstructured":"Woodhall, G. L., Bailey, S. J., Thompson, S. E., Evans, D. I. & Jones, R. S. Fundamental differences in spontaneous synaptic inhibition between deep and superficial layers of the rat entorhinal cortex. Hippocampus \n                           15, 232\u2013245 (2005).","journal-title":"Hippocampus"},{"key":"1444_CR81","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.nbd.2004.09.005","volume":"18","author":"M von Kienlin","year":"2005","unstructured":"von Kienlin, M. et al. Altered metabolic profile in the frontal cortex of PS2APP transgenic mice, monitored throughout their life span. Neurobiol. Dis. \n                           18, 32\u201339 (2005).","journal-title":"Neurobiol. Dis."},{"key":"1444_CR82","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/j.neuint.2010.04.001","volume":"56","author":"RM Salek","year":"2010","unstructured":"Salek, R. M. et al. A metabolomic study of the CRND8 transgenic mouse model of Alzheimer\u2019s disease. Neurochem. Int. \n                           56, 937\u2013947 (2010).","journal-title":"Neurochem. Int."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-01444-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-01444-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-01444-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T17:42:26Z","timestamp":1671730946000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-01444-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,13]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["1444"],"URL":"https:\/\/doi.org\/10.1038\/s41467-017-01444-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,13]]},"assertion":[{"value":"4 December 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1464"}}